Why the study?
Despite improvements in care, disparities in cardiac arrest-related mortality among heart failure patients persist, motivating an exploration of demographic patterns and mortality rates.
While overall cardiac arrest mortality in heart failure patients declined from 1999 to 2023, significant disparities persist for men, Black individuals, and rural populations, alongside a notable mortality spike during the COVID-19 pandemic.
Declining cardiac arrest mortality in heart failure warrants ongoing surveillance; this cohort study leaves open drivers of disparities and the 2018-2021 rise.
Background Cardiac arrest (CA) is a significant cause of mortality in patients with heart failure (HF). Despite improvements in care, disparities in CA-related mortality among HF patients persist. This study seeks to explore demographic patterns and mortality rates. Methods CDC WONDER (1999-2023) data was analyzed to assess CA-related mortality in HF patients aged≥25. Using the Joinpoint regression analysis, we calculated age-adjusted mortality rates (AAMR) per 100,000 patients and average annual percentage changes (AAPC) to analyze the mortality trends. Results CA is responsible for a staggering 1,139,963 deaths among HF patients. The AAMRs have decreased from 25.3 in 1999 to 20.6 in 2023 (AAPC: -0.88, p-value < 0.01), the decline was most significant from 1999 to 2011 (APC: -2.95, p < 0.01) before a concerning rise from 2018 to 2021 (APC: 5.10, p-value < 0.01). Disparities are evident, with men facing higher AAMRs than women (24.6 vs. 17.6) and Black individuals at the highest risk (AAMR: 28.8) followed by Hispanics (AAMR: 22.8). Regionally, Mississippi reports the highest AAMR at 52.5, contrasting with Maryland’s lowest rate of 4.3. Moreover, rural areas exhibited higher AAMRs than urban settings (20.9 vs. 20.1). Conclusion The rising mortality rates from CA in HF patients—especially among men, Black individuals, and those in rural areas—require our immediate attention. By implementing targeted interventions and enhancing access to healthcare, we can reduce these disparities and improve patient outcomes.
No takes yet. Share an insight, caveat, or question.
Muhammad et al. (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: